BLUE News Alert Bluebird Bio Inc (BLUE) 90.70 02/14/2015 00:

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 1:03 AM

Bluebird Bio Inc (BLUE) 90.70 $BLUE

Will Masimo Corp (MASI) Disappoint Q4 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:30AM CST
Our proven model does not conclusively show that Masimo Corp (MASI) is likely to beat earnings this quarter.
BLUE: 90.70 (+0.93), ACT: 285.37 (+3.71), MASI: 27.38 (-0.21), HLS: 45.01 (+0.30)

Biotech Stock Mailbag: MannKind, Mast Therapeutics, Bluebird
at The Street - Fri Feb 13, 5:00AM CST
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
BLUE: 90.70 (+0.93), MSTX: 0.47 (+0.01), MNKD: 7.00 (+0.02)

Biotech Stocks: What's Hot, What's Not - As Seen By Market-Makers, Their Clients
Peter F. Way, CFA - at Seeking Alpha - Wed Feb 11, 11:37AM CST

MDVN: 104.71 (+0.67), BLUE: 90.70 (+0.93), BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), ALXN: 182.29 (+6.02), TGTX: 13.13 (-0.19), TKMR: 21.45 (-0.22), ANAC: 40.76 (-0.07), PBYI: 205.26 (+2.75), REGN: 402.40 (+0.66)

What's in Store for Acadia Healthcare (ACHC) this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 11:50AM CST
Acadia Healthcare Company, Inc. (ACHC) is set to report its fourth-quarter and full year 2014 earnings results on Feb 11
BLUE: 90.70 (+0.93), ACHC: 63.20 (-0.45), ACT: 285.37 (+3.71), ALNY: 95.54 (+1.67)

Seeking Alpha's Biotech Weekly: Questioning Gilead, MannKind To Market, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 06, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
SGYP: 2.98 (unch), BLUE: 90.70 (+0.93), ZIOP: 9.64 (-0.35), MYGN: 34.03 (+0.40), PSTI: 2.91 (+0.01), PFE: 34.64 (-0.23), XON: 39.30 (+1.05), TKMR: 21.45 (-0.22), ASPX: 65.76 (+2.76), MNKD: 7.00 (+0.02), HSP: 87.35 (unch), ZTS: 45.46 (-0.33), ANTM: 141.05 (-0.95), WMGI: 25.68 (+0.17), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), THOR: 40.01 (+0.54), TEVA: 56.77 (-0.58), ABBV: 58.05 (+1.00), SNY: 49.42 (+0.82), ARNA: 4.55 (+0.02)

7 Companies We'd Buy and Hold for the Next 20 Years
Motley Fool Staff - Motley Fool - Fri Feb 06, 2:11PM CST
At The Motley Fool, we take a long-term view on investing. With that in mind, we asked seven of our analysts for their favorite stocks to hold for the next 20 years and beyond. Here's what they had to say. One company I'm interested in buying and...
BLUE: 90.70 (+0.93), TD: 44.57 (+0.14), PFE: 34.64 (-0.23), MO: 54.76 (-0.78), WM: 51.29 (-1.41), CELG: 115.88 (+0.16), PM: 82.87 (-0.82), V: 269.63 (-1.28), BAX: 70.39 (+0.31), AGIO: 118.55 (+0.11), AAPL: 127.08 (+0.62), MA: 87.14 (-0.38)

Not For The Faint Of CAR-T: The CAR-T Landscape In Early 2015
EP Vantage - Seeking Alpha - Fri Feb 06, 1:26PM CST
This is an extract from a longer report. If you followed last year's explosion of enthusiasm in CAR therapies you might have assumed that this was a super-novel approach that had just burst onto the scientific stage. In fact work on the synthetic...
BLUE: 90.70 (+0.93), CLRB: 2.45 (+0.28), BLCM: 20.00 (-0.81), KITE: 62.59 (+0.82), JUNO: 40.52 (+0.18), NVS: 102.20 (-0.17)

Biotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, Hemispherx
at The Street - Fri Feb 06, 5:05AM CST
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
BLUE: 90.70 (+0.93), ADXS: 7.18 (+0.06), GILD: 101.90 (+1.10), HEB: 0.25 (+0.01), ACHN: 10.89 (-0.20), MRK: 58.81 (-0.07), ABBV: 58.05 (+1.00)

bluebird bio's Thalassemia Drug Gets Breakthrough Status - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 5:20PM CST
bluebird bio, Inc.'s (BLUE) LentiGlobin BB305 received Breakthrough status from the FDA for transfusion-dependent patients with beta-thalassemia major.
BLUE: 90.70 (+0.93), BIIB: 391.66 (-0.45), AMGN: 153.48 (+0.30), AMAG: 41.49 (+0.23)

bluebird bio to Present at the Leerink Global Healthcare Conference
Business Wire - Thu Feb 05, 6:00AM CST
bluebird bio, Inc. (Nasdaq: BLUE) today announced that management will present at the Leerink Global Healthcare Conference on Thursday, February 12, 2015 at 8:05 a.m. EST. The conference is being held February 11-12, 2015 at the Waldorf Astoria Hotel in New York City.
BLUE: 90.70 (+0.93)

Bluebird Bio (BLUE) Weak On High Volume Today
at The Street - Tue Feb 03, 9:01AM CST
Trade-Ideas LLC identified bluebird bio (BLUE) as a weak on high relative volume candidate
BLUE: 90.70 (+0.93)

Bellicum Pharmaceuticals: Has The Bell Finally Tolled For Cancer?
Looking For Diogenes - at Seeking Alpha - Mon Feb 02, 2:43PM CST

BLUE: 90.70 (+0.93), BLCM: 20.00 (-0.81), KITE: 62.59 (+0.82), JUNO: 40.52 (+0.18), NVS: 102.20 (-0.17), CELG: 115.88 (+0.16)

Bluebird's LentiGlobin BB305 a Breakthrough Therapy for blood disorder
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 7:00AM CST

BLUE: 90.70 (+0.93)

FDA Grants Breakthrough Therapy Designation to LentiGlobin for Treatment of Beta-Thalassemia Major
Business Wire - Mon Feb 02, 6:00AM CST
bluebird bio, Inc. (Nasdaq:BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to LentiGlobin(R) BB305 Drug Product for the treatment of transfusion-dependent patients with beta-thalassemia major.
BLUE: 90.70 (+0.93)

The Top Healthcare Stock to Buy in February
Motley Fool Staff, Dan Caplinger, Todd Campbell, and Cheryl Swanson - Motley Fool - Sun Feb 01, 5:54AM CST
No one knows whether a stock is going to pop or drop in any given month or year, but our Motley Fool contributors say specific catalysts could move each of these three stocks higher over the next month, and that might be reason for investors to...
BLUE: 90.70 (+0.93), AGN: 229.49 (+1.87), ACT: 285.37 (+3.71), UNH: 109.44 (-0.40), AGIO: 118.55 (+0.11), CELG: 115.88 (+0.16)

Winners Circle 2014 Top Hedge Fund Managers: Healthcare Funds, Nine Of Top Ten Spots
GuruFundPicks - at Seeking Alpha - Thu Jan 29, 7:04PM CST

BLUE: 90.70 (+0.93), ABMD: 60.39 (+0.46), AUXL: 36.47 (-0.06), ASPX: 65.76 (+2.76), AAVL: 36.29 (+0.01)

Bluebird bio CSO to transition to advisory role
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 3:57PM CST

BLUE: 90.70 (+0.93)

bluebird bio Announces Transition of Chief Scientific Officer
Business Wire - Thu Jan 29, 3:05PM CST
bluebird bio, Inc. (Nasdaq: BLUE) a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases, today announced that Mitchell H. Finer, Ph.D., chief scientific officer (CSO), has decided to transition from his current role with bluebird bio over the next six months. At the end of this transition period, he will remain an important scientific voice at bluebird bio by serving on the company's scientific advisory board (SAB) and continuing to share his experience and insights to benefit the company's scientific strategy. The company is now initiating the process of recruiting for a CSO replacement.
BLUE: 90.70 (+0.93)

Biotech Stocks Technical Analysis - Achillion Pharma, Array BioPharma, Rexahn Pharma, Neurocrine Biosciences, and Bluebird Bio
PR Newswire - Tue Jan 27, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Array BioPharma Inc. (NASDAQ: ARRY), Rexahn Pharmaceuticals Inc. (NYSE MKT: RNN), Neurocrine Biosciences Inc. (NASDAQ: NBIX), and Bluebird Bio Inc. (NASDAQ: BLUE). Free research report on Achillion Pharma can be accessed at http://get.Investor-Edge.com/pdf/?c=Achillion...amp;s=ACHN. On Monday, January 26, 2015, the NASDAQ Composite ended at 4,771.76, up 0.29%, the Dow Jones Industrial Average advanced 0.03%, to finish the day at 17,678.70, and the S&P 500 closed at 2,057.09, up 0.26%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 825.01, up 0.45%, with the index also advancing 9.36% in the previous three months. Register for your complimentary reports at the links given below.
BLUE: 90.70 (+0.93), RNN: 0.75 (+0.01), NBIX: 37.22 (+0.27), ACHN: 10.89 (-0.20), ARRY: 8.05 (+0.08)

5 Cant-Miss Reasons Why Celgene Corporation Could Soar
Todd Campbell, The Motley Fool - Motley Fool - Mon Jan 26, 7:04AM CST
Source: Celgene Corporation Celgene Corporation 's slate of top selling medicines already makes it one of biotech's biggest success stories, but Celgene's recent long-term forecast suggests that the company's best days are ahead of it. Here are...
BLUE: 90.70 (+0.93), JNJ: 99.62 (+1.18), AGIO: 118.55 (+0.11), XLRN: 38.02 (+0.07), CELG: 115.88 (+0.16)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

INSPIRE 2026: Luxury Hotel Trends and Investments

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Tenant Improvement: Key to Adapting Lease Spaces

Adapting Space or Adapting Business? Here's the thing that keeps popping up in commercial real estate: tenant improvement construction. This isn't just modifying a structure—it's about rethinking how businesses operate within a certain space. The HelloNation article gives you the lowdown straight from Bradley Quakenbush of White Oak Commercial Group. When businesses...

Noé Hinojosa Jr. Honored for Leadership in Business

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Sarah Weede: A Force in Veterans Services Leadership

Saluting a Veteran's Advocate Amidst a world obsessed with bottom lines and market swings, it’s refreshing to spotlight someone like Sarah R. Weede. She's not about the Wall Street grind but you better believe her drive and dedication rival any big-shot CEO. Leadership in Veterans Services Sarah Weede's story starts with substantial roots planted in serving those who...

VISTAR Oakland Workers Join Teamsters for Unity

Warehouse Workers Break Free from the Shackles Ever had that feeling, where enough is enough? That's where 37 warehouse workers at VISTAR find themselves, shaking off the dust and signing up with Teamsters Local 853. This ain't just a fleeting wind of change; it's the whole damn storm. Turning Points and Union Victories Think about it. This move by the VISTAR warehouse...

Navigating AI Laws: A New Era for Privacy & Security

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

Spooky Suds: House of Horror Meets El Car Wash

A Haunted Wash Awaits Miami Drivers Picture this: you're cruising down West Flagler on a regular Wednesday evening, but tonight, you're not just rolling in for a rinse. Nope, this Wednesday night, the wash tunnel at El Car Wash gets downright spooky. It's getting a haunted house makeover with scare actors from the House of Horror. When a Car Wash Becomes a Haunted...